E6AP was originally identified as the ubiquitin-protein ligase involved in human papillomavirus (HPV) E6-mediated p53 degradation and has since been shown to act as an E3 ubiquitin-protein ligase in the ubiquitination of several other protein substrates. To further define E6AP function at the molecular and cellular levels, a ribozyme-based gene inactivation approach was adopted. A library of hammerhead ribozymes, with randomized arm sequences, was used to screen active molecules along the entire E6AP transcript for ribozyme-cleavable sites. Ligation-anchored PCR was adapted to detect cleavage products, and ribozymes designed to the selected sites were characterized both in vitro and in vivo. Ribozyme-mediated reduction in E6AP expression was found to enhance the apoptotic response of HeLa cells to mitomycin C-induced DNA damage. These findings suggest that E6AP has potential as a drug target, as its suppression can potentiate apoptosis in HPV-positive cells treated with a cytotoxic drug. Cancer Gene Therapy (2003) 10, 707-716. doi:10.1038/sj.cgt.7700623Keywords: E6AP; gene function; apoptosis; ribozyme; in vitro selection T he ubiquitin-dependent proteolytic pathway has emerged as a crucial mechanism in cellular regulation. 1 Protein ubiquitination involves a cascade of cellular enzymes called E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme) and E3 (ubiquitin-protein ligase). Ubiquitin is activated at its C-terminal glycine to form a thiolester with the active site cysteine on E1 in an ATP-dependent reaction. The activated ubiquitin is then transferred to one of a family of E2s, preserving the high-energy thiolester bond. E2 enzymes catalyze isopeptide bond formation between ubiquitin and substrate protein directly or in association with an E3. Multiubiquitinated proteins are recognized by a large multisubunit protease complex, the 26S proteosome and degraded.The 100 kDa cellular protein E6AP, in association with human papillomavirus (HPV) E6, was initially identified as a ubiquitin-protein ligase responsible for p53 degradation. 2 It has since been shown that E6AP acts as an E3 in the ubiquitin-dependent proteolysis of various other cellular proteins, both in the presence and absence of HPV E6. 3-7 E6AP was also the founding member of a family of structurally related E3s carrying a carboxyl terminus that is highly conserved among various organisms, termed the hect domain (homology to E6AP C terminus). 8 Besides its protein ligase function, E6APwas recently shown to act as a coactivator in nuclear hormone receptor-mediated transactivation, 9 and mutations in E6AP have been causally linked with a genetic neurological disorder known as Angelman Syndrome. 10,11 Despite the identification of several E6AP-interacting proteins, the role of E6AP in cellular physiology remains poorly understood. Recent works from several groups suggest that E6AP may be involved in the regulation of important cellular processes such as transcription, signal transduction, cell survival and/or apoptosis, cell-cycle contr...